Production of recombinant human midkine in yeast, Pichia pastoris

被引:10
作者
Murasugi, A [1 ]
Tohma-Aiba, Y [1 ]
Asami, Y [1 ]
机构
[1] Meiji Milk Prod Co Ltd, Meiji Cell Technol Ctr, Odawara, Kanagawa 2500862, Japan
关键词
human midkine; protein production; Pichia pastoris;
D O I
10.1263/jbb.90.395
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Recombinant human midkine was expressed in the cells of Pichia pastoris under the control of the AOX1 gene promoter. The expression of midkine was efficiently induced by methanol in a high cell density fermentation. Approximately 0.3 g/l culture of midkine accumulated in the cells by 72 h after induction. When the cells were disrupted, midkine was recovered in an insoluble form, and was insoluble even in the presence of 7 M urea. The precipitate was dissolved in the buffer solution (pH 8) containing 8M guanidine hydrochloride, 10 mM dithiothreitol, I mM EDTA and 50 mM Tris-Cl, and then, midkine was renatured by dialysis at high concentration against the buffer solution (pH 8) containing 0.5 M sodium chloride and 20 mM Tris-Cl. The renatured midkine was recovered using a SP-Sepharose column, and purified further by Heparin-Sepharose column chromatography. Approximately 64 mg/l culture of the purified midkine was obtained. The amino acid sequence of amino-terminus and the amino acid composition of midkine were the same as those of Met-midkine that has a methionine residue at the amino-teminus. Mass spectrometry of purified Met-midkine showed a mass of 13370.7 Da (average), almost the theoretical mass for it. The Met-midkine enhanced the proliferation of Chinese hamster ovary (CHO) cells.
引用
收藏
页码:395 / 399
页数:5
相关论文
共 19 条
[1]  
Cregg JM, 1999, GENE EXPRESSION SYSTEMS, P157, DOI 10.1016/B978-012253840-7/50007-9
[2]   STRUCTURAL CHARACTERIZATION OF NATIVE AND RECOMBINANT FORMS OF THE NEUROTROPHIC CYTOKINE MK [J].
FABRI, L ;
MARUTA, H ;
MURAMATSU, H ;
MURAMATSU, T ;
BURGESS, AW ;
NICE, EC .
JOURNAL OF CHROMATOGRAPHY, 1993, 646 (01) :213-225
[3]  
Higgins DR, 1998, METH MOL B, V103, P1
[4]  
Hopkins SA, 1992, PHARM ENG, V12, P48
[5]  
Inui T, 1996, J PEPT SCI, V2, P28
[6]   Solution structure of midkine, a new heparin-binding growth factor [J].
Iwasaki, W ;
Nagata, K ;
Hatanaka, H ;
Inui, T ;
Kimura, T ;
Muramatsu, T ;
Yoshida, K ;
Tasumi, M ;
Inagaki, F .
EMBO JOURNAL, 1997, 16 (23) :6936-6946
[7]   SYNTHETIC PEPTIDES DERIVED FROM MIDKINE ENHANCE PLASMINOGEN-ACTIVATOR ACTIVITY IN BOVINE AORTIC ENDOTHELIAL-CELLS [J].
KOJIMA, S ;
INUI, T ;
KIMURA, T ;
SAKAKIBARA, S ;
MURAMATSU, H ;
AMANUMA, H ;
MARUTA, H ;
MURAMATSU, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (02) :468-473
[8]  
Kurtz A, 1995, CRIT REV ONCOGENESIS, V6, P151
[9]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[10]   MIDKINE (MK), A RETINOIC ACID (RA)-INDUCIBLE GENE-PRODUCT, PRODUCED IN E-COLI ACTS ON NEURONAL AND HL-60 LEUKEMIA-CELLS [J].
MARUTA, H ;
BARTLETT, PF ;
NURCOMBE, V ;
NUREKAMAL, MSA ;
CHOMIENNE, C ;
MURAMATSU, T ;
MURAMATSU, H ;
FABRI, L ;
NICE, E ;
BURGESS, AW .
GROWTH FACTORS, 1993, 8 (02) :119-134